<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39441353</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-0584</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>23</Day></PubDate></JournalIssue><Title>Annals of hematology</Title><ISOAbbreviation>Ann Hematol</ISOAbbreviation></Journal><ArticleTitle>Aplastic Anemia in the light of the COVID-19 pandemic: infection, vaccination, and pathophysiologic mechanisms.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00277-024-06052-9</ELocationID><Abstract><AbstractText>Patients infected with SARS-CoV-2 and vaccinated against COVID-19 could develop aplastic anemia (AA). Comprehensive review and analysis were conducted through a selective literature search in PubMed, Scopus, EMBASE, and Web of Science. For this analysis, 26 studies were included, comprising 16 case reports, 7 case series, and 3 observational studies, totaling 53 patients. The causes of acquired or idiopathic AA are diverse; this review presents recent findings, including possible new etiologies such as SARS-CoV-2 infection and COVID-19 vaccines. This possible association is explored, addressing the existing gap, and aiming to improve daily medical practice. This article reviews the relationship between AA and SARS-CoV-2 infection, as well as COVID-19 vaccines, analyzing cases of de novo occurrence and relapses of AA. Although a definitive mechanistic link has not yet been established, possible underlying pathophysiological mechanisms are explored.</AbstractText><CopyrightInformation>© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cahuapaza-Gutierrez</LastName><ForeName>Nelson Luis</ForeName><Initials>NL</Initials><Identifier Source="ORCID">0000-0002-1228-1941</Identifier><AffiliationInfo><Affiliation>Facultad de Ciencias de La Salud, Carrera de Medicina Humana, Universidad Científica del Sur, Lima, Perú. 100065659@cientifica.edu.pe.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CHANGE Research Working Group, Universidad Científica del Sur, Lima, Perú. 100065659@cientifica.edu.pe.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Ann Hematol</MedlineTA><NlmUniqueID>9107334</NlmUniqueID><ISSNLinking>0939-5555</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Aplastic Anemia</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">COVID-19 Vaccines</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2 Vaccines (Source: Medical Subject Headings of the National Library of Medicine (MeSH NLM))</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>23</Day><Hour>12</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>23</Day><Hour>12</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>23</Day><Hour>11</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39441353</ArticleId><ArticleId IdType="doi">10.1007/s00277-024-06052-9</ArticleId><ArticleId IdType="pii">10.1007/s00277-024-06052-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hadj Hassine I (2022) Covid-19 vaccines and variants of concern: a review. Rev Med Virol 32(4):e2313</Citation><ArticleIdList><ArticleId IdType="pubmed">34755408</ArticleId><ArticleId IdType="doi">10.1002/rmv.2313</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Coronavirus (COVID-19) Dashboard [Internet]. [citado 3 de abril de 2023]. Disponible en: https://covid19.who.int. Accessed 9 Oct 2024</Citation></Reference><Reference><Citation>Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS et al (2020) Extrapulmonary manifestations of COVID-19. Nat Med 26(7):1017–1032</Citation><ArticleIdList><ArticleId IdType="pubmed">32651579</ArticleId><ArticleId IdType="doi">10.1038/s41591-020-0968-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Alahyari S, Moradi M, Rajaeinejad M, Jalaeikhoo H (2022) Post-COVID-19 hematologic complications: a systematic review. Expert Rev Hematol 15(6):539–546</Citation><ArticleIdList><ArticleId IdType="pubmed">35584541</ArticleId><ArticleId IdType="doi">10.1080/17474086.2022.2080051</ArticleId></ArticleIdList></Reference><Reference><Citation>Beladiya J, Kumar A, Vasava Y, Parmar K, Patel D, Patel S et al (2024) Safety and efficacy of COVID-19 vaccines: a systematic review and meta-analysis of controlled and randomized clinical trials. Rev Med Virol 34(1):e2507</Citation><ArticleIdList><ArticleId IdType="pubmed">38282394</ArticleId><ArticleId IdType="doi">10.1002/rmv.2507</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharif N, Alzahrani KJ, Ahmed SN, Dey SK (2021) Efficacy, immunogenicity and safety of COVID-19 vaccines: a systematic review and meta-analysis. Front Immunol 12:714170</Citation><ArticleIdList><ArticleId IdType="pubmed">34707602</ArticleId><ArticleId IdType="pmc">8542872</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2021.714170</ArticleId></ArticleIdList></Reference><Reference><Citation>Jafarzadeh A, Jafarzadeh S, Pardehshenas M, Nemati M, Mortazavi SMJ (2023) Development and exacerbation of autoimmune hemolytic anemia following COVID-19 vaccination: a systematic review. Int J Lab Hematol 45(2):145–155</Citation><ArticleIdList><ArticleId IdType="pubmed">36208056</ArticleId><ArticleId IdType="doi">10.1111/ijlh.13978</ArticleId></ArticleIdList></Reference><Reference><Citation>Amisha F, Saluja P, Malik P, Van Rhee F (2023) Acquired hemophilia A (AHA) due to anti-SARS-CoV-2 vaccination: a systematic review. EJHaem 4(2):532–543</Citation><ArticleIdList><ArticleId IdType="pubmed">37206259</ArticleId><ArticleId IdType="pmc">10188482</ArticleId><ArticleId IdType="doi">10.1002/jha2.604</ArticleId></ArticleIdList></Reference><Reference><Citation>Cvetković M, Pantić N, Virijević M, Pravdić Z, Sabljić N, Mitrović M et al (2023) Relapse of Evans syndrome following BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine: case report and literature review. J Infect Dev Ctries 17(6):800–804</Citation><ArticleIdList><ArticleId IdType="pubmed">37406068</ArticleId><ArticleId IdType="doi">10.3855/jidc.17719</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarrah K, Al Mahmasani L, Atoui A, Bou-Fakhredin R, Taher AT (2022) Manifestation of paroxysmal nocturnal hemoglobinuria after COVID-19 mRNA vaccination. Blood Cells Mol Dis 93:102641</Citation><ArticleIdList><ArticleId IdType="pubmed">34980554</ArticleId><ArticleId IdType="doi">10.1016/j.bcmd.2021.102641</ArticleId></ArticleIdList></Reference><Reference><Citation>Urbanowicz I, Nahaczewska W, Celuch B (2021) Narrative review of aplastic anemia-the importance of supportive treatment. Ann Palliat Med 10(1):694–699</Citation><ArticleIdList><ArticleId IdType="pubmed">33353360</ArticleId><ArticleId IdType="doi">10.21037/apm-20-1957</ArticleId></ArticleIdList></Reference><Reference><Citation>Durrani J, Groarke EM (2022) Clonality in immune aplastic anemia: Mechanisms of immune escape or malignant transformation. Semin Hematol 59(3):137–142</Citation><ArticleIdList><ArticleId IdType="pubmed">36115690</ArticleId><ArticleId IdType="pmc">9938528</ArticleId><ArticleId IdType="doi">10.1053/j.seminhematol.2022.08.001</ArticleId></ArticleIdList></Reference><Reference><Citation>DeZern AE, Churpek JE (2021) Approach to the diagnosis of aplastic anemia. Blood Adv 5(12):2660–2671</Citation><ArticleIdList><ArticleId IdType="pubmed">34156438</ArticleId><ArticleId IdType="pmc">8270669</ArticleId><ArticleId IdType="doi">10.1182/bloodadvances.2021004345</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee NCJ, Patel B, Etra A, Bat T, Ibrahim IF, Vusirikala M et al (2022) SARS-CoV-2 infection associated with aplastic anemia and pure red cell aplasia. Blood Adv 6(13):3840–3843</Citation><ArticleIdList><ArticleId IdType="pubmed">35452511</ArticleId><ArticleId IdType="pmc">9040401</ArticleId><ArticleId IdType="doi">10.1182/bloodadvances.2022007174</ArticleId></ArticleIdList></Reference><Reference><Citation>Cecchi N, Giannotta JA, Barcellini W, Fattizzo B (2022) A case of severe aplastic anaemia after SARS-CoV-2 vaccination. Br J Haematol 196(6):1334–1336</Citation><ArticleIdList><ArticleId IdType="pubmed">34783367</ArticleId><ArticleId IdType="doi">10.1111/bjh.17947</ArticleId></ArticleIdList></Reference><Reference><Citation>Avenoso D, Marsh JCW, Potter V, Pagliuca A, Slade S, Dignan F et al (2022) SARS-CoV-2 infection in aplastic anemia. Haematologica 107(2):541–543</Citation><ArticleIdList><ArticleId IdType="pubmed">34670361</ArticleId><ArticleId IdType="doi">10.3324/haematol.2021.279928</ArticleId></ArticleIdList></Reference><Reference><Citation>Miano M, Dufour C (2015) The diagnosis and treatment of aplastic anemia: a review. Int J Hematol 101(6):527–535</Citation><ArticleIdList><ArticleId IdType="pubmed">25837779</ArticleId><ArticleId IdType="doi">10.1007/s12185-015-1787-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Figlerowicz M, Mania A, Lubarski K, Lewandowska Z, Służewski W, Derwich K et al (2020) First case of convalescent plasma transfusion in a child with COVID-19-associated severe aplastic anemia. Transfus Apher Sci Off J World Apher Assoc Off J Eur Soc Haemapheresis 59(5):102866</Citation></Reference><Reference><Citation>Hock H, Kelly HR, Meyerowitz EA, Frigault MJ, Massoth LR (2021) Case 31–2021: A 21-year-old man with sore throat, epistaxis, and oropharyngeal petechiae. N Engl J Med 385(16):1511–1520</Citation><ArticleIdList><ArticleId IdType="pubmed">34644476</ArticleId><ArticleId IdType="pmc">8531984</ArticleId><ArticleId IdType="doi">10.1056/NEJMcpc2027096</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranjima M, Gobbur RH (2021) Severe aplastic anemia secondary to SARS CoV-2 infection- a case report. J Pediatr Perinatol Child Health 5(4):230–237</Citation></Reference><Reference><Citation>Sumbly V, Siddiqui R, Alshamam M, Kurbanova T, Rizzo V (2021) New onset aplastic anemia after a COVID-19 infection: a case report. Am J Med Case Rep 9:451–455</Citation></Reference><Reference><Citation>Chakravarthy R, Murphy ML, Ann Thompson M, McDaniel HL, Zarnegar-Lumley S, Borinstein SC (2022) SARS-CoV-2 infection coincident with newly diagnosed severe aplastic anemia: a report of two cases. Pediatr Blood Cancer 69(4):e29433</Citation><ArticleIdList><ArticleId IdType="pubmed">34767303</ArticleId><ArticleId IdType="doi">10.1002/pbc.29433</ArticleId></ArticleIdList></Reference><Reference><Citation>Iannuzzi A, Parrella A, De Ritis F, Cammarota A, Berloco L, Paudice F et al (2022) Pancytopenia in a case of aplastic anaemia/paroxysmal nocturnal haemoglobinuria unmasked by SARS-CoV-2 infection: a case report. Med Kaunas Lith 58(9):1282</Citation></Reference><Reference><Citation>Nejatifar F, Hesni E, Samadani AA (2023) A novel case report of severe aplastic anemia with COVID infection. Ethiop J Health Sci 33(1):177–181</Citation><ArticleIdList><ArticleId IdType="pubmed">36890930</ArticleId><ArticleId IdType="pmc">9987292</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X, Mo Y, Wen K, Ming R, Yin X, Hu L et al (2023) Acquired aplastic anaemia after SARS-CoV-2 infection in China: a case report. Front Pediatr 11:1277540</Citation><ArticleIdList><ArticleId IdType="pubmed">38027266</ArticleId><ArticleId IdType="pmc">10661920</ArticleId><ArticleId IdType="doi">10.3389/fped.2023.1277540</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguilar JJ, Dhillon V, Balasubramanian S (2024) Manifestation of pancytopenia associated with COVID-19 as paroxysmal nocturnal hemoglobinuria (PNH) and aplastic anemia (AA). Hematol Rep 16(1):42–49</Citation><ArticleIdList><ArticleId IdType="pubmed">38247995</ArticleId><ArticleId IdType="pmc">10801523</ArticleId><ArticleId IdType="doi">10.3390/hematolrep16010005</ArticleId></ArticleIdList></Reference><Reference><Citation>Youssef MAM, Ahmed ES, Kamal DT, Elsayh KI, Abdelfattah MA, Mahran HH et al (2024) Clinical signs and treatment of new-onset bone marrow failure associated SARS-CoV-2 infection in children: a single institution prospective cohort study. Mediterr J Hematol Infect Dis 16(1):e2024034</Citation><ArticleIdList><ArticleId IdType="pubmed">38468844</ArticleId><ArticleId IdType="pmc">10927230</ArticleId><ArticleId IdType="doi">10.4084/MJHID.2024.034</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed P, Chaudhry QUN, Satti TM, Mahmood SK, Ghafoor T, Shahbaz N et al (2020) Epidemiology of aplastic anemia: a study of 1324 cases. Hematol Amst Neth 25(1):48–54</Citation></Reference><Reference><Citation>Norasetthada L, Wongkhantee S, Chaipokam J, Charoenprasert K, Chuncharunee S, Rojnuckarin P et al (2021) Adult aplastic anemia in Thailand: incidence and treatment outcome from a prospective nationwide population-based study. Ann Hematol 100(10):2443–2452</Citation><ArticleIdList><ArticleId IdType="pubmed">34269837</ArticleId><ArticleId IdType="pmc">8440252</ArticleId><ArticleId IdType="doi">10.1007/s00277-021-04566-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Zhao J, Li R, Pan H, Gao Z, Li W et al (2023) Low risk of relapse in aplastic anemia patients after SARS-CoV-2 omicron infection: a prospective NICHE cohort. Am J Hematol 98(10):E272–E275</Citation><ArticleIdList><ArticleId IdType="pubmed">37449449</ArticleId><ArticleId IdType="doi">10.1002/ajh.27028</ArticleId></ArticleIdList></Reference><Reference><Citation>Paton C, Mathews L, Groarke EM, Rios O, Lotter J, Patel BA et al (2021) COVID-19 infection in patients with severe aplastic anaemia. Br J Haematol 193(5):902–905</Citation><ArticleIdList><ArticleId IdType="pubmed">33928632</ArticleId><ArticleId IdType="pmc">8165020</ArticleId><ArticleId IdType="doi">10.1111/bjh.17415</ArticleId></ArticleIdList></Reference><Reference><Citation>Amanati A, Hedayati SB, Ziyaeyan M, Honar A, Dashtianeh R, Rabiei N et al (2022) A fatal SARS-coronavirus-2 induced bone marrow aplasia complicated with invasive fungal infection and severe neutropenic enterocolitis. BMC Infect Dis 22(1):682</Citation><ArticleIdList><ArticleId IdType="pubmed">35945491</ArticleId><ArticleId IdType="pmc">9361242</ArticleId><ArticleId IdType="doi">10.1186/s12879-022-07599-6</ArticleId></ArticleIdList></Reference><Reference><Citation>King KY, Goodell MA (2011) Inflammatory modulation of HSCs: viewing the HSC as a foundation for the immune response. Nat Rev Immunol 11(10):685–692</Citation><ArticleIdList><ArticleId IdType="pubmed">21904387</ArticleId><ArticleId IdType="pmc">4154310</ArticleId><ArticleId IdType="doi">10.1038/nri3062</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanza C, Romenskaya T, Manetti AC, Franceschi F, La Russa R, Bertozzi G et al (2022) Cytokine Storm in COVID-19: Immunopathogenesis and Therapy. Med Kaunas Lith 58(2):144</Citation></Reference><Reference><Citation>Hirano T, Murakami M (2020) COVID-19: a new virus, but a familiar receptor and cytokine release syndrome. Immunity 52(5):731–733</Citation><ArticleIdList><ArticleId IdType="pubmed">32325025</ArticleId><ArticleId IdType="pmc">7175868</ArticleId><ArticleId IdType="doi">10.1016/j.immuni.2020.04.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Giudice V, Selleri C (2022) Aplastic anemia: pathophysiology. Semin Hematol 59(1):13–20</Citation><ArticleIdList><ArticleId IdType="pubmed">35491054</ArticleId><ArticleId IdType="doi">10.1053/j.seminhematol.2021.12.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Li S, Liu J, Liang B, Wang X, Wang H et al (2020) Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine 55:102763</Citation><ArticleIdList><ArticleId IdType="pubmed">32361250</ArticleId><ArticleId IdType="pmc">7165294</ArticleId><ArticleId IdType="doi">10.1016/j.ebiom.2020.102763</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B, Huang S, Yin L (2021) The cytokine storm and COVID-19. J Med Virol 93(1):250–256</Citation><ArticleIdList><ArticleId IdType="pubmed">32592501</ArticleId><ArticleId IdType="doi">10.1002/jmv.26232</ArticleId></ArticleIdList></Reference><Reference><Citation>de Bruin AM, Voermans C, Nolte MA (2014) Impact of interferon-γ on hematopoiesis. Blood 124(16):2479–2486</Citation><ArticleIdList><ArticleId IdType="pubmed">25185711</ArticleId><ArticleId IdType="doi">10.1182/blood-2014-04-568451</ArticleId></ArticleIdList></Reference><Reference><Citation>Elahi S (2022) Hematopoietic responses to SARS-CoV-2 infection. Cell Mol Life Sci CMLS 79(3):187</Citation><ArticleIdList><ArticleId IdType="pubmed">35284964</ArticleId><ArticleId IdType="doi">10.1007/s00018-022-04220-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison AG, Lin T, Wang P (2020) Mechanisms of SARS-CoV-2 transmission and pathogenesis. Trends Immunol 41(12):1100–1115</Citation><ArticleIdList><ArticleId IdType="pubmed">33132005</ArticleId><ArticleId IdType="pmc">7556779</ArticleId><ArticleId IdType="doi">10.1016/j.it.2020.10.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Zambidis ET, Park TS, Yu W, Tam A, Levine M, Yuan X et al (2008) Expression of angiotensin-converting enzyme (CD143) identifies and regulates primitive hemangioblasts derived from human pluripotent stem cells. Blood 112(9):3601–3614</Citation><ArticleIdList><ArticleId IdType="pubmed">18728246</ArticleId><ArticleId IdType="pmc">2572789</ArticleId><ArticleId IdType="doi">10.1182/blood-2008-03-144766</ArticleId></ArticleIdList></Reference><Reference><Citation>Park TS, Zambidis ET (2009) A role for the renin-angiotensin system in hematopoiesis. Haematologica 94(6):745–747</Citation><ArticleIdList><ArticleId IdType="pubmed">19483149</ArticleId><ArticleId IdType="pmc">2688560</ArticleId><ArticleId IdType="doi">10.3324/haematol.2009.006965</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratajczak MZ, Kucia M (2020) SARS-CoV-2 infection and overactivation of Nlrp3 inflammasome as a trigger of cytokine «storm» and risk factor for damage of hematopoietic stem cells. Leukemia 34(7):1726–1729</Citation><ArticleIdList><ArticleId IdType="pubmed">32483300</ArticleId><ArticleId IdType="pmc">7262681</ArticleId><ArticleId IdType="doi">10.1038/s41375-020-0887-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratajczak MZ, Bujko K, Cymer M, Thapa A, Adamiak M, Ratajczak J et al (2020) The Nlrp3 inflammasome as a «rising star» in studies of normal and malignant hematopoiesis. Leukemia 34(6):1512–1523</Citation><ArticleIdList><ArticleId IdType="pubmed">32313108</ArticleId><ArticleId IdType="pmc">7266743</ArticleId><ArticleId IdType="doi">10.1038/s41375-020-0827-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Kucia M, Ratajczak J, Bujko K, Adamiak M, Ciechanowicz A, Chumak V et al (2021) An evidence that SARS-Cov-2/COVID-19 spike protein (SP) damages hematopoietic stem/progenitor cells in the mechanism of pyroptosis in Nlrp3 inflammasome-dependent manner. Leukemia 35(10):3026–3029</Citation><ArticleIdList><ArticleId IdType="pubmed">34163002</ArticleId><ArticleId IdType="pmc">8219510</ArticleId><ArticleId IdType="doi">10.1038/s41375-021-01332-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Peslak SA, Olson T, Babushok DV (2017) Diagnosis and treatment of aplastic anemia. Curr Treat Options Oncol 18(12):70</Citation><ArticleIdList><ArticleId IdType="pubmed">29143887</ArticleId><ArticleId IdType="pmc">5804354</ArticleId><ArticleId IdType="doi">10.1007/s11864-017-0511-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Viallard JF, Boiron JM, Parrens M, Moreau JF, Ranchin V, Reiffers J et al (2000) Severe pancytopenia triggered by recombinant hepatitis B vaccine. Br J Haematol 110(1):230–233</Citation><ArticleIdList><ArticleId IdType="pubmed">10931005</ArticleId><ArticleId IdType="doi">10.1046/j.1365-2141.2000.02171.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashok Shenoy K, Prabha Adhikari MR, Chakrapani M, Shenoy D, Pillai A (2001) Pancytopenia after recombinant hepatitis B vaccine–an Indian case report. Br J Haematol 114(4):955</Citation><ArticleIdList><ArticleId IdType="pubmed">11564093</ArticleId><ArticleId IdType="doi">10.1046/j.1365-2141.2001.03006-2.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah C, Lemke S, Singh V, Gentile T (2004) Case reports of aplastic anemia after vaccine administration. Am J Hematol 77(2):204</Citation><ArticleIdList><ArticleId IdType="pubmed">15389916</ArticleId><ArticleId IdType="doi">10.1002/ajh.20153</ArticleId></ArticleIdList></Reference><Reference><Citation>Angelini P, Kavadas F, Sharma N, Richardson SE, Tipples G, Roifman C et al (2009) Aplastic anemia following varicella vaccine. Pediatr Infect Dis J 28(8):746</Citation><ArticleIdList><ArticleId IdType="pubmed">19633522</ArticleId><ArticleId IdType="doi">10.1097/INF.0b013e31819b6c1f</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnini I, Scappini B, Guidi S, Longo G, Bosi A (2012) Acquired severe aplastic anemia after H1N1 influenza virus vaccination successfully treated with allogeneic bone marrow transplantation. Ann Hematol 91(3):475–476</Citation><ArticleIdList><ArticleId IdType="pubmed">21681390</ArticleId><ArticleId IdType="doi">10.1007/s00277-011-1278-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Röth A, Bertram S, Schroeder T, Haverkamp T, Voigt S, Holtkamp C et al (2022) Acquired aplastic anemia following SARS-CoV-2 vaccination. Eur J Haematol 109(2):186–194</Citation><ArticleIdList><ArticleId IdType="pubmed">35592930</ArticleId><ArticleId IdType="pmc">9347507</ArticleId><ArticleId IdType="doi">10.1111/ejh.13788</ArticleId></ArticleIdList></Reference><Reference><Citation>Sridhara S, Nair R, Stanek M (2022) Severe aplastic anemia after receiving SARS-CoV-2 Moderna mRNA vaccination. J Hematol 11(1):34–39</Citation><ArticleIdList><ArticleId IdType="pubmed">35356634</ArticleId><ArticleId IdType="pmc">8929201</ArticleId><ArticleId IdType="doi">10.14740/jh954</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabata S, Hosoi H, Murata S, Takeda S, Mushino T, Sonoki T (2022) Severe aplastic anemia after COVID-19 mRNA vaccination: causality or coincidence? J Autoimmun 126:102782</Citation><ArticleIdList><ArticleId IdType="pubmed">34920343</ArticleId><ArticleId IdType="doi">10.1016/j.jaut.2021.102782</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Laczko D, Caponetti GC, Rabatin S, Babushok DV (2022) Severe aplastic anaemia after serial vaccinations for SARS-CoV-2, pneumococcus and seasonal influenza. EJHaem 3(3):983–988</Citation><ArticleIdList><ArticleId IdType="pubmed">35941884</ArticleId><ArticleId IdType="pmc">9348402</ArticleId><ArticleId IdType="doi">10.1002/jha2.443</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo S, Kim B, Lee SC, Kim MS, Yoon YA, Choi YJ (2022) Very severe immune aplastic anemia after mRNA vaccination against COVID-19 responds well to immunosuppressive therapy: clinical characteristics and comparison to previous reports. Hematol Amst Neth 27(1):1191–1195</Citation></Reference><Reference><Citation>Chen CY, Chen TT, Hsieh CY, Lien MY, Yeh SP, Chen CC (2023) Case reports of management of aplastic anemia after COVID-19 vaccination: a single institute experience in Taiwan. Int J Hematol 117(1):149–152</Citation><ArticleIdList><ArticleId IdType="pubmed">36057889</ArticleId><ArticleId IdType="doi">10.1007/s12185-022-03445-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Fattizzo B, Pasquale R, Croci GA, Pettine L, Cassanello G, Barcellini W (2023) Aplastic anemia after SARS-CoV-2 infection or vaccines: case series and literature review. Blood Transfus Trasfus Sangue 22(3):266</Citation></Reference><Reference><Citation>Kmira Z, Sabrine K, Monia G, Imen A, Dorra C, Rania B et al (2023) A case of acquired aplastic anemia after severe hepatitis- probably induced by the Pfizer/BioNTech vaccine: a case report and review of literature. Vaccines 11(7):1228</Citation><ArticleIdList><ArticleId IdType="pubmed">37515043</ArticleId><ArticleId IdType="pmc">10384467</ArticleId><ArticleId IdType="doi">10.3390/vaccines11071228</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi M, Mori A, Oda Y, Yokoyama E, Kanaya M, Izumiyama K et al (2023) New onset of hypomegakaryocytic thrombocytopenia with the potential for progression to aplastic anemia after BNT162b2 mRNA COVID-19 vaccination. Int J Hematol 118(4):477–482</Citation><ArticleIdList><ArticleId IdType="pubmed">37219678</ArticleId><ArticleId IdType="pmc">10203663</ArticleId><ArticleId IdType="doi">10.1007/s12185-023-03618-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Pvs S, Koka H, Suvvari TK, Mounish Reddy R, Godavari ST, Thomas V (2023) An unusual case of acquired aplastic anemia following SARS-CoV-2 vaccination: a case report. IDCases 33:e01826</Citation><ArticleIdList><ArticleId IdType="pubmed">37360926</ArticleId><ArticleId IdType="pmc">10279557</ArticleId><ArticleId IdType="doi">10.1016/j.idcr.2023.e01826</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto M, Keino D, Sumii S, Yokosuka T, Goto H, Inui A et al (2023) Severe Hepatitis-associated aplastic anemia following COVID-19 mRNA vaccination. Intern Med Tokyo Jpn 62(12):1813–1816</Citation><ArticleIdList><ArticleId IdType="doi">10.2169/internalmedicine.1308-22</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajput RV, Ma X, Boswell KL, Gaudinski M, Gordon I, Novik L et al (2022) Clinical outcomes and immune responses to SARS-CoV-2 vaccination in severe aplastic anaemia. Br J Haematol 199(5):679–687</Citation><ArticleIdList><ArticleId IdType="pubmed">36128909</ArticleId><ArticleId IdType="doi">10.1111/bjh.18456</ArticleId></ArticleIdList></Reference><Reference><Citation>Pothast CR, van Dijk K, Pool ES, Halkes CJM, Heemskerk MHM, Tjon JML (2023) SARS-CoV-2 mRNA vaccination of aplastic anemia patients is safe and effective. Am J Hematol 98(2):E20–E23</Citation><ArticleIdList><ArticleId IdType="pubmed">36371670</ArticleId><ArticleId IdType="doi">10.1002/ajh.26780</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffin M, Eikema DJ, Verheggen I, Kulagin A, Tjon JML, Fattizzo B et al (2024) SARS-CoV-2 vaccination in 361 non-transplanted patients with aplastic anemia and/or paroxysmal nocturnal hemoglobinuria. Haematologica 109(1):283–286</Citation><ArticleIdList><ArticleId IdType="pubmed">37584297</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Xu Z, Wang P, Li XM, Shuai ZW, Ye DQ et al (2022) New-onset autoimmune phenomena post-COVID-19 vaccination. Immunology 165(4):386–401</Citation><ArticleIdList><ArticleId IdType="pubmed">34957554</ArticleId><ArticleId IdType="doi">10.1111/imm.13443</ArticleId></ArticleIdList></Reference><Reference><Citation>Teijaro JR, Farber DL (2021) COVID-19 vaccines: modes of immune activation and future challenges. Nat Rev Immunol 21(4):195–197</Citation><ArticleIdList><ArticleId IdType="pubmed">33674759</ArticleId><ArticleId IdType="pmc">7934118</ArticleId><ArticleId IdType="doi">10.1038/s41577-021-00526-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Verbeke R, Hogan MJ, Loré K, Pardi N (2022) Innate immune mechanisms of mRNA vaccines. Immunity 55(11):1993–2005</Citation><ArticleIdList><ArticleId IdType="pubmed">36351374</ArticleId><ArticleId IdType="pmc">9641982</ArticleId><ArticleId IdType="doi">10.1016/j.immuni.2022.10.014</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomou EE, Keyvanfar K, Young NS (2006) T-bet, a Th1 transcription factor, is up-regulated in T cells from patients with aplastic anemia. Blood 107(10):3983–3991</Citation><ArticleIdList><ArticleId IdType="pubmed">16434488</ArticleId><ArticleId IdType="pmc">1895294</ArticleId><ArticleId IdType="doi">10.1182/blood-2005-10-4201</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberhardt V, Luxenburger H, Kemming J, Schulien I, Ciminski K, Giese S et al (2021) Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine. Nature 597(7875):268–273</Citation><ArticleIdList><ArticleId IdType="pubmed">34320609</ArticleId><ArticleId IdType="pmc">8426185</ArticleId><ArticleId IdType="doi">10.1038/s41586-021-03841-4</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>